. 2019 Jul 11;70(10):2121–2130. doi: 10.1093/cid/ciz638

Table 3.

All-Cause In-Hospital Mortality in Immunocompromised vs Nonimmunocompromised Adults Hospitalized With Laboratory-confirmed Influenza In the US Influenza Hospitalization Surveillance Network, 2011–2015

	aOR of Mortality	95% CI
Primary analysis^a	1.46	1.20–1.76
Sensitivity analysis^a,b	1.42	1.21–1.66

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval.

^aControlling for age, sex, race/ethnicity, influenza vaccination, underlying medical conditions (smoking, obesity, chronic lung disease, cardiovascular disease, chronic metabolic disease, neuromuscular disorders, neurologic disorders, renal disease, liver disease), antiviral use, and influenza season.

^bIncluding receipt of steroid therapy in the immunocompromised group.